scispace - formally typeset
H

Hyo Ihl Chang

Researcher at Korea University

Publications -  79
Citations -  2200

Hyo Ihl Chang is an academic researcher from Korea University. The author has contributed to research in topics: Bacteriophage & Temperateness. The author has an hindex of 24, co-authored 79 publications receiving 2013 citations.

Papers
More filters
Journal ArticleDOI

A novel electrochemically active and Fe(III)-reducing bacterium phylogenetically related to Clostridium butyricum isolated from a microbial fuel cell

TL;DR: Cyclic voltammetry showed that Clostridium butyricum EG3 cells were electrochemically active, a novel characteristic of strict anaerobic Gram-positive bacteria, suggesting that Fe(III) ion is utilised as an electron sink.
Journal ArticleDOI

The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes.

TL;DR: AX is a PPAR-α agonist and PPar-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes by measuring peroxisome proliferator-activated receptors (PPAR) activity.
Journal ArticleDOI

Protective effect of astaxanthin on naproxen-induced gastric antral ulceration in rats.

TL;DR: Results suggest that astaxanthin removes the lipid peroxides and free radicals induced by naproxen, and it may offer potential remedy of gastric ulceration.
Journal ArticleDOI

Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells.

TL;DR: The results suggest that astaxanthin, probably due to its antioxidant activity, inhibits the production of inflammatory mediators by blocking iNOS and COX-2 activation or by the suppression of iN OS and COx-2 degradation.
Journal ArticleDOI

Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid.

TL;DR: Cyanidin likely acts as a physiological PPARα agonist and potentially for PPARβ/δ and γ, and reduces hepatic lipid concentrations by rewiring the expression of genes involved in lipid metabolic pathways.